Prendio-BioProcure Launches New Generative AI, Analytics, and Workflow Automation Capabilities Enhancing its Market Leading Life Sciences P2P Technology Solution

New AI-driven automation, real-time analytics, and CRO Discovery capabilities eliminate inefficiencies, giving biotech companies more time and capital to focus on scientific breakthroughs.

BOSTON, March 25, 2025 /PRNewswire/ -- Today, Prendio-BioProcure, the leading provider of procurement solutions built for biotech from seed through IPO, announced the launch of its most advanced set of capabilities to date, enabling cost savings, further workflow automation, and supplier intelligence to R&D-driven organizations. These innovations enable biotech companies to stretch their financial runway, reduce administrative overhead, and make faster, data-driven decisions, all within a seamless, AI-powered procurement platform.

For many emerging biotech companies, access to capital has become increasingly challenging. Manual procurement processes and generic procurement technology solutions paired with a complex life sciences supplier ecosystem often slow down progress and drive-up costs. Prendio-BioProcure's latest release tackles these challenges head-on with biotech-designed capabilities, enabling scientists and biotech leaders to spend less time on administrative tasks and more time on discovery.

"Biotech companies are solving some of the world's toughest challenges, and our mission is to give them the tools to move faster and more efficiently," said Eric Meizlish, CEO of Prendio-BioProcure. "This launch is about enabling biotech teams to focus on their science, not procurement headaches. By simplifying workflows, enhancing spend management, and streamlining supplier engagement, we help our customers extend their financial runway and reinvest in what matters most: innovation."

One of the most anticipated capabilities in this release is Prendio's expanded CRO Discovery Tool, recognized for its ability to cut weeks off the search for the right contract research organization (CRO). Biotech companies have traditionally spent countless hours navigating fragmented databases, reaching out across their networks, and relying on word-of-mouth to find service providers for essential preclinical and clinical research. Prendio-BioProcure has transformed this process, leveraging its proprietary dataset built across more than 500 biotech customers and over $3B of CRO work to provide immediate, data-backed CRO recommendations, ensuring biotech companies find the right specialized partners faster.

"At Prendio, we're committed to evolving the way our customers work, freeing them up to focus on groundbreaking science," said Micah Litow, Chief Product and Solutions Officer at Prendio. "CRO Discovery transforms the search for CRO partners, eliminating tedious manual efforts. Leveraging a proprietary data set built over the past decade, we deliver tailored, high-quality matches within minutes. This capability and others in today's launch are about accelerating research and empowering our customers to stay focused on what matters most."

Beyond CRO Discovery, Prendio-BioProcure's latest AI-powered automation and analytics capabilities continue to drive cost savings and efficiency across biotech procurement operations. New features include:

• OCR AI-Enabled Three-Way Match: Eliminates manual invoice matching errors with up to 95% accuracy.
• PO Analytics Dashboard: Provides real-time spend tracking enabling data-based decision making to empower biotech executive teams to extend cash runway.
• Integrated Payments & Supplier Spend Management Solutions: Strengthen financial controls and implement spend management programs.

"Prendio has helped us achieve meaningful cost savings and operational efficiency, giving us more room to focus resources on our goal of bringing products to patients," said Jaclyn Kegel, Finance Director at Precision BioSciences. "The system is easy to use and navigate and the support we receive from Prendio and BioProcure is exceptional. We're looking forward to how these upcoming enhancements will further improve visibility and automation, helping us make even more informed spending decisions and maximize the impact of our resources and time."

With powerful automation, deep biotech expertise, and real-time intelligence, Prendio-BioProcure is redefining what's possible in biotech procurement.

About Prendio-BioProcure:
Prendio-BioProcure provides specialized procurement solutions tailored for the life sciences industry. Designed for biotechs, our software and services streamline purchasing, ensure compliance, and enable companies to stay focused on innovation. Learn more at https://www.prendio.com/whats-new-at-prendio

SOURCE Prendio-BioProcure